Member Info for Aldebaran

90% of patience taking avacta s drug ava6000 have seen there salivary gland cancers stopped in its tracks. There is currently no way to treat this disease at this stage currently and annual sales eclipse avacta market cap so yes share price is down over the period you said but doesn't take a genius to see it will out perform boom multi fold as approvals come in over next 6 months.

Anyway, since you try slate avacta you don't no difference between price and value. Avacta is undervalues whereas boom is grossly overvalued prove me wrong

At least avacta has a USP haha

Unlike this. Anyway no need to discuss other shares this is for audioboom

The usp seems to be the podcasts however to keep and even attract them you need to pay a fortune so there fees are ever rising which is why the company can't do anything other than report EBITDA.

Ifso facto. There is no USP.

Prove me wront

Remind me of tye USP again

Let's just remember u guys were saying this was a screaming buy at over 600p just a few weeks back and what did Alde say?

I see 140p coming again because I think the stock as been pumped and dumped based of nothing just hipe

Price as held up since the allocation date that is what I am saying

So if they are selling there is plenty of appetite for the shares and if there not then why not?

Forgive me for not seeing the buzz about a 5th rate podcast company with no USP and no signs of profits for the foreseeable future

No way to no I'm talking off price action generally. Holding up very well

Very unusual price action following heights allocation. Really positive

Apart from the fact avacta have 3.5yrs of exceptional trial data and have said they're open to partnering this year you mean? Lol

But yeah rights issue placing disasters is the only way avacta can survive. I'd give here a wide birth if you believe that's the case

Until these spin a profit it'll forever be a traders play thing. Could see this being ramped and did try to warn. I'm expecting 140p again soon

Concur. They're happy to take 100k

Interesting

It is possible that they've seen what we all see and want to hold for a bit now but unlikely. They aren't experts in biotech, there just a loan company. Not ruling it out just think it's more likely there us a buyer for there stock now OR avacta are in talks with them about improving the terms of our CLN as they can all see that if they keep dumping each quarter we're all gonna be out of pocket even heights so it's in there interest to negotiate also. Perhaps pay back every half year instead or avacta have asked for a payment brake or 2 much like you can with private loans and mortgages...

Either way they are not selling and I can't see that as anything but positive. Management I know for a fact btw not opinion but fact are working incredibly hard behind the scenes on this they know how important it is and it will be resolved very soon. Watch this space

Especially as no standard off care for this. It just screams accelerated approval.

ODD expected this year for it also

Nice little £XXXm sales opportunity for someone from likely next year. Wonder how much that alone is worth to avacta

Agree LLP.

People need to remember that heights have no regard for avacta. They are a loan company and couldn't care less what we are doing and what are plans are. They haven't cared previously. They get there allowance and they dump.

What is obvious is something has changed now. Why?

It can only be positive I.e. they are selling to sticky hands behind the scenes or they are holding themselves for a certain time, why? If they expect price to go down you'd expect them to dump quickly.

Something is up

Where as he gone he was saying about significant off book dark trading activities for Avacta and was going to provide a update for us all. He seemed certain his system had identified this and I was starting to believe him. Now gone quite

They don't appear to be selling and if they are then price ain't dropping. Highly unusual for the period immediate after there allocation and with AACR behind us

This 150Bn black hole in pharma revenues is becoming a bugger and bigger threat make no mistake about it. I think ideally BP would wait for P2 data, this is what CC herself even said recently but can they afford to wait, can they risk a competitor getting there hands on precision and exasperating there patent cliffs. I don't think so.

Already pharma valuations are dropping. Was looking at AZ share chat earlier and there investors are becoming concerned so be sure there BOARD will feel the pressure all BP boards will. Arguably there is a lot more at stake for them than us.

P1b patients selected based on slfn11 and fap and open to much healthier patients. No reason to expect results to be anything other than amazing.

Given dox is just dox, given BP urgency to replace lost revenues & given the quantity of exceptional data available. BP will be ready to deal here before p2 data comes in of that am certain

Https://x.com/BowTiedBiotech/status/1918072725282914689?t=hye3yLLFvV-lvH1ABuuw0w&s=19

Doug your not even deramping properly. The chart support is actually at 22p.

Everybody the CHART SUPPORT IS AT 22P.

that loud enough for you Dougie m8?? That's what you wanted wasn't it really. Well we all know and don't care charts are all about probability and news trumps technicals. We are sat on one of the most extra ordinary oncology brake through in the last half century and are ready to make commercial deals on our terms. When the time is right. Most long term holders believe that time is weeks if not days away now so some random weirdo rocking up on here spouting about technicals which he doesn't even read properly isn't going to scare anyone into selling. That's me done interacting with you now ur clearly crazy and are here just to disrupt